COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,740 Articles (22,502 medRxiv, 8,238 bioRxiv)

Most recent first Previous |  Page 2048: Articles 20471-20480  | Next

Performance characteristics of a rapid SARS-CoV-2 antigen detection assay at a public plaza testing site in San Francisco
Pilarowski, G., Lebel, P., Sunshine, S., Liu, J., Crawford, E., Marquez, C., Rubio, L., Chamie, G., Martinez, J., Peng, J., Black, D., Wu, W., Pak, J., Laurie, M. T., Jones, D., Miller, S., Jacobo, J., Rojas, S., Rojas, S., Nakamura, R., Tulier-Laiwa, V., Petersen, M., Havlir, D. V., The CLIAHUB Consortium, , DeRisi, J.
10.1101/2020.11.02.20223891 — Posted: 2020-11-04 Discussion: Onsite
SARS-CoV-2 responsive T cell numbers are associated with protection from COVID-19: A prospective cohort study in keyworkers
WYLLIE, D. H., Mulchandani, R., Jones, H. E., Taylor-Phillips, S., Brooks, T., Charlett, A., Ades, A., Study Investigators, E.-H., Makin, A., Oliver, I.
10.1101/2020.11.02.20222778 — Posted: 2020-11-04 Discussion: Offsite
Cell phone mobility data reveals heterogeneity in stay-at-home behavior during the SARS-CoV-2 pandemic
Levin, R., Chao, D. L., Wenger, E. A., Proctor, J. L.
10.1101/2020.10.31.20223776 — Posted: 2020-11-04 Discussion: Onsite
Randomized controlled trial of convalescent plasma therapy against standard therapy in patients with severe COVID-19 disease
AlQahtani, M., Abdulrahman, A., AlMadani, A., AlAli, S. Y., Al Zamrooni, A. M., Hejab, A., Wasif, P., Conroy, R., Atkin, S., Otoom, S., AlSayed, M. A.
10.1101/2020.11.02.20224303 — Posted: 2020-11-04
Low dose hydroxychloroquine is associated with lower mortality in COVID-19: a meta-analysis of 26 studies and 44,521 patients
Di Castelnuovo, A., Costanzo, S., Cassone, A., Cauda, R., de Gaetano, G., Iacoviello, L.
10.1101/2020.11.01.20223958 — Posted: 2020-11-04
Risk factors for outcomes of COVID-19 patients: an observational study of 795 572 patients in Russia
Demkina, A. E., Morozov, S., Vladzymyrskyy, A. V., Kljashtorny, V. G., Guseva, O. I., Pugachev, P. S., Artemova, O. R., Reshetnikov, R. V., Gombolevskiy, V. A., Ryabinina, M. N.
10.1101/2020.11.02.20224253 — Posted: 2020-11-04
Emergence of Novel SARS-CoV-2 Variants in the Netherlands
Urhan, A., Abeel, T.
10.1101/2020.11.02.20224352 — Posted: 2020-11-04
High attack rates of SARS-CoV-2 infection through household-transmission: a prospective study
Kuwelker, K., Zhou, F., Blomberg, B., Lartey, S., Brokstad, K. A., Trieu, M. C., Madsen, A., Krammer, F., Mohn, K. G. I., Toendel, C., Linchausen, D. W., Cox, R. J., Langeland, N.
10.1101/2020.11.02.20224485 — Posted: 2020-11-04 Discussion: Onsite
Cohorting of Non-Critically Ill COVID-19 Patients: A Multicenter Survey Study (COVID-COHORT)
Purohit, U., Fralick, M.
10.1101/2020.11.01.20194233 — Posted: 2020-11-04
Understanding COVID-19 testing pathways in English care homes to identify the role of point-of-care testing: an interview-based process mapping study
Micocci, M., Gordon, A., Allen, J., Hicks, T., Kierkegaard, P., McLister, A., Walne, S., Buckle, P.
10.1101/2020.11.02.20224550 — Posted: 2020-11-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).